CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
28.81
0.38%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.23
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 28.7
Open 27.51
1-Year Change 69.08%
Day's Range 27.51 - 28.81
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 23, 2024 28.70 1.36 4.97% 27.34 28.81 26.43
Jul 22, 2024 28.37 1.25 4.61% 27.12 28.47 27.06
Jul 19, 2024 27.82 0.45 1.64% 27.37 28.03 27.09
Jul 18, 2024 27.21 -0.55 -1.98% 27.76 28.84 26.69
Jul 17, 2024 28.68 2.70 10.39% 25.98 28.94 25.24
Jul 16, 2024 26.95 1.10 4.26% 25.85 26.96 25.85
Jul 15, 2024 26.70 0.22 0.83% 26.48 27.01 26.00
Jul 12, 2024 26.91 1.41 5.53% 25.50 26.94 25.50
Jul 11, 2024 26.01 0.84 3.34% 25.17 26.16 25.17
Jul 10, 2024 25.25 1.28 5.34% 23.97 25.67 23.97
Jul 9, 2024 24.51 0.33 1.36% 24.18 24.93 24.18
Jul 8, 2024 24.18 -0.85 -3.40% 25.03 25.64 24.15
Jul 5, 2024 25.27 0.18 0.72% 25.09 26.97 24.53
Jul 3, 2024 25.68 1.07 4.35% 24.61 25.77 23.75
Jul 2, 2024 24.52 0.06 0.25% 24.46 24.78 24.13
Jul 1, 2024 24.87 2.07 9.08% 22.80 25.12 22.62
Jun 28, 2024 23.42 0.93 4.14% 22.49 23.82 22.47
Jun 27, 2024 22.12 -0.86 -3.74% 22.98 23.35 21.97
Jun 26, 2024 22.52 -1.50 -6.24% 24.02 24.17 21.74
Jun 25, 2024 24.39 -0.49 -1.97% 24.88 25.79 23.85

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

XOMA Corporation Company profile

About XOMA Corp

XOMA Corporation (XOMA) is a biotechnology royalty aggregator. The Company's drug royalty aggregator business is focused on early to mid-stage clinical assets primarily in Phase I and II. XOMA acquires pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The Company's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. The Company's royalty-aggregator business includes acquiring additional licenses to programs with third-party funding and has more than 70 assets. XOMA royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087); mezagitamab (TAK-079), iscalimab (CFZ533), and MK-4830.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, XOMA Corp revenues increased 30% to $38.2M. Net income applicable to common stockholders decreased 12% to $8M. Revenues reflect Europe segment increase of 40% to $35M, United States segment increase from $1.3M to $2.6M. Net income was offset by Stock-based Compensation in SGA increase of 56% to $6.2M (expense).

Equity composition

Common Stock $.0075 Par, 03/11, 46,666,666 auth., 29,510,963 issd. Insiders own 7.83%. PO: 4/91, 3.4M shs @ $26.50 by Alex. Brown& Sons. PO 6/01, 3M shs @ $15 by U.S. Bancorp Piper Jaffray. Series B Prfd. Stock $.05 Par, 8K auth., 2,959 issd. *1996, Co.'s 4% Conv. Subd. Debentures were conv. into 2M shs. of Common. 08/10, 1-for-15 reverse split.

Industry: Bio Therapeutic Drugs

Suite 310
2200 Powell Street
EMERYVILLE
CALIFORNIA 94608
US

People also watch

US100

19,240.60 Price
-2.710% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

66,455.95 Price
+0.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,427.33 Price
+0.740% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 21:00 (UTC)
Spread 0.30

ETH/USD

3,424.54 Price
-2.000% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading